FBFrancesco Camara Blumetti

Francesco Camara Blumetti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Francesco Camara Blumetti has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • José Antonio Pinto

    Universidade Federal de Sao Paulo, Sao Paulo, Brasil

    7 shared publications
  • Akira Ishida

    Universidade Federal de São Paulo; Orthopaedics and Traumatology; Rua Borges Lagoa, 783 - 5º andar São Paulo São Paulo Brazil 0438-032

    6 shared publications
  • Eiffel Tsuyoshi Dobashi

    6 shared publications
  • José A Pinto

    Universidade Federal de São Paulo; Department of Orthopaedics and Traumatology; Rua Borges Lagoa, 783 - 5º andar São Paulo São Paulo Brazil 04038-032

    4 shared publications
  • João Carlos Belloti

    Universidade Federal de São Paulo; Department of Orthopaedics and Traumatology; Rua Borges Lagoa, 783 - 5º andar São Paulo São Paulo Brazil 04038-032

    3 shared publications
  • Talissa Oliveira Generoso

    Department of Sports Medicine Midwest Orthopaedics at Rush University Medical Center Chicago Illinois USA

    3 shared publications

Latest Publications

  • Open Access

    Assessment of the Brazilian Portuguese Version Selective Control Assessment of the Lower Extremity (SCALE) After Translation and Cross-Cultural Adaptation

    by Douglas Manuel Carrapeiro Prina, Elizabeth de Alvarenga Borges da Fonseca, Pothyra Campos Pascoal, Francesco Camara Blumetti, Monica Paschoal Nogueira

    Background/Objectives: This study aims to translate and validate the Selective Control Assessment of the Lower Extremity (SCALE) tool from English into Portuguese. Methods: SCALE was translated into Portuguese independently by two native Portuguese translators and synthesized into a single manuscript: SCALE-BR. Using this test in patients with spastic cerebral palsy, the internal consistency (Cronbach’s α), reliability by intra-class correlation (ICC), and validity compared with the Gross Motor Function Classification System (GMFCS) scores were evaluated. Results: 30 patients diagnosed with spastic cerebral palsy were assessed, with a predominance of males (66.7%), a mean age of 12.9 ± 7.9 (4–38 years) and a majority of diparetic patients (73.3%) and GMFCS I (53.3%). Spearman’s correlation coefficient, R2 = −0.84, p < 0.001, revealed an inverse relationship between the SCALE instrument and the GMFCS, corroborating the findings in the literature. There was an excellent intra- and interobserver agreement (ICC > 0.75). Conclusions: The Portuguese version of the questionnaire was effective, proving to be reproducible and reliable among different evaluators and patients, with an inverse correlation with the GMFCS as expected in the literature.

  • Open Access

    Epiphyseal displacement of the distal humerus in a neonate: a case report

    by Talissa Oliveira Generoso, Susana dos Reis Braga, Francesco Camara Blumetti, Maurício Pegoraro, Amancio Ramalho

    Epiphyseal displacement of the distal humerus is rare and difficult to diagnose. In addition, the literature on the prognosis and treatment is limited. Here, we present a case of distal humeral physeal separation with significant displacement in a neonate. A favorable outcome was obtained following closed reduction and percutaneous fixation with Kirschner wires assisted by arthrography. This report adds valuable information on this subject to the existing literature. Epiphyseal displacement of the distal humerus in a neonate: a case


  • Open Access

    Idiopathic Toe Walking: What’s New? An Integrative Review

    by Letícia D’Ordaz Lhano Santos, Talissa Oliveira Generoso, Luiz Renato Agrizzi De Angeli, Francesco Camara Blumetti, Filipe Machado Barcelos

    Background: Idiopathic Toe Walking (ITW) is the persistence of a forefoot strike pattern at initial contact while walking beyond the age of three years, in the absence of other justifiable causes. This review aims to consolidate the current knowledge on the subject and to highlight recent advancements in literature. Methods: We conducted an electronic search in the following databases up to June 2023: Ovid MEDLINE, EBSCO, Embase, CINAHL Plus, and PubMed. The PICO framework was employed to define search terms. Results: Despite considerable methodological heterogeneity among studies, we found a stronger inclination toward investigating etiological and prognostic factors. There is a trend for a higher prevalence in boys with a positive family history. Novel classifications have been proposed to improve differential diagnosis. Among conservative treatment options, there is stronger evidence for gait improvement with the use of serial casting followed by orthoses. Severe cases may benefit from surgical Zone III gastrocsoleus lengthening. Conclusion: Further studies with standardized methodologies are required to clarify questions about the etiology, classification, and treatment of this condition. Nonetheless, there is a higher level of evidence supporting conservative treatments with serial casting and orthoses, as well as gastrocsoleus Zone III surgical lengthening for severe cases in the second decade of life.

  • Open Access

    O ângulo de Baumann: Uma análise da teoria à prática

    by Talissa O. Generoso, Giovani M. Pacifico Junior, Filipe M. Barcelos, Francesco C. Blumetti, Susana R. Braga, Amâncio Ramalho Junior

    Resumo: Objetivo Analisar como o ângulo de Baumann (AB) é afetado por inclinações radiográficas inadequadas. Métodos Estudo realizado a partir de radiografias do úmero distal de crianças de 3 a 10 anos. Foram comparadas as aferições do AB realizadas por cinco observadores, e cada radiografia foi avaliada quanto à sua qualidade em “adequada” ou “inadequada”. A correlação entre a qualidade radiográfica e a normalidade dos ângulos foi avaliada. Resultados Amostra composta por 141 pacientes, 44% entre 3 e 6 anos e 56% entre 7 e 10. Observamos AB entre 52,01 e 89,82 graus, tendo cerca de 16% das medidas fora dos limites de normalidade da literatura. Um total de 33,3% das radiografias avaliadas foram classificadas como “inadequadas”. Sobre as medidas do AB fora do parâmetro da normalidade, observamos que sua proporção foi maior entre as imagens com qualidade radiográfica inadequada (31,1% vs. 6,2%), tendo essa diferença se mostrado significativa (p < 0,001). Conclusões O AB é uma medida muito variável e, isoladamente, pouco confiável para a avaliação de deformidades angulares do cotovelo pediátrico, tendo a qualidade radiográfica se mostrado um fator causal importante dessa variabilidade.


  • Open Access

    Fratura por avulsão da tuberosidade da tíbia em adolescente: Relato de caso

    by Giovani Manhabusqui Pacífico Júnior, Marcel Lobato Sauma, Lauro Augusto Veloso Costa, Luiz Fabiano Presente Taniguchi, Francesco Camara Blumetti

    Resumo: O presente estudo tem como objetivo relatar um caso raro de fratura por avulsão da tuberosidade da tíbia em adolescente. Um paciente de 14 anos, do sexo masculino, sofreu entorse de joelho esquerdo durante partida de futebol. No primeiro atendimento em pronto-socorro, ele apresentava dor no joelho esquerdo, edema 2 +/4 + , incapacidade de deambulação e de flexo-extensão do joelho acometido, sem alterações neurovasculares ou sinais de síndrome compartimental. Nas radiografias, identificou-se fratura fisária na tíbia proximal esquerda, classificada por Ogden, Tross e Murphy, com modificação por Ryu e Debenham, como tipo IV, e complementada por Aerts et al. como tipo IV-B. Foi realizada imobilização com tala gessada inguino-maleolar e analgesia, e o paciente submetido a cirurgia no dia seguinte, com redução aberta e fixação interna utilizando parafusos canulados 4,5 mm. O paciente recebeu alta no dia seguinte à cirurgia, sendo mantida a imobilização com tala gessada e a restrição de carga por quatro semanas, e apresentou consolidação óssea confirmada por radiografia com três meses do pós-operatório. O paciente evoluiu sem discrepância de comprimento dos membros inferiores, arco de movimento igual ao do membro contralateral, e sem queixas no seguimento de um ano.


  • Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy

    by Francesco C Blumetti, João Carlos Belloti, Marcel Js Tamaoki, José A Pinto

    Background Cerebral palsy (CP) is the most common cause of physical disabilities in children in high‐income countries. Spasticity is the most common motor disturbance in CP. Botulinum toxin type A (BoNT‐A) is considered the first‐line treatment for focal spasticity in people with CP. Objectives To evaluate the effectiveness and safety of BoNT‐A compared to other treatments used in the management of lower limb spasticity in children with CP. Search methods We searched CENTRAL, PubMed, four other databases, and two trial registers in October 2018. We also searched the reference lists of relevant studies and reviews and contacted experts in the field. We did not apply any date or language restrictions. Selection criteria Randomised controlled trials of children with CP, aged between birth and 19 years, treated with BoNT‐A injections in the lower limb muscles compared to other interventions. The primary outcomes were gait analysis and function. The secondary outcomes were joint range of motion, quality of life, satisfaction, spasticity, and adverse events. Data collection and analysis Two review authors independently selected studies, extracted data, assessed risk of bias, and rated the quality of the evidence using GRADE. A third review author arbitrated in case of disagreements. We conducted meta‐analyses of available data whenever possible, analysing dichotomous data with risk ratios (RR), and continuous data with mean differences (MD) or standardised mean differences (SMD), with 95% confidence intervals (CI). We considered a 5% significance level for all analyses. Whenever possible, we analysed outcomes at the time points at which they were assessed: short term (2 to 8 weeks); medium term (12 to 16 weeks); and long term (> 24 weeks). Main results We included 31 randomised controlled trials assessing 1508 participants. Most studies included ambulatory patients with more than one motor type of CP, and with a mean age of between three and seven years. There was a slight predominance of males. Studies compared BoNT‐A in the lower limb muscles to usual care or physiotherapy (14 studies), placebo or sham (12 studies), serial casting (4 studies), or orthoses (1 study). We rated studies as at high or unclear risk of bias mainly due to random sequence generation, allocation concealment, blinding of participants and personnel, and blinding of outcome assessment. BoNT‐A versus usual care or physiotherapy BoNT‐A might improve overall gait scores at medium‐term follow‐up (MD 2.80, 95% CI 1.55 to 4.05; 1 study, 40 children; very low‐quality evidence) and is moderately effective at improving function at short‐term (SMD 0.59, 95% CI 0.23 to 0.95; 2 studies, 123 children) and medium‐term (SMD 1.04, 95% CI 0.16 to 1.91; 4 studies, 191 children) follow‐up (all very low‐quality evidence). BoNT‐A improves ankle range of motion, satisfaction, and ankle plantarflexors spasticity at one or more time points (very low‐quality evidence). The proportion of adverse events in the BoNT‐A group was 0.37 (95% CI 0.08 to 0.66; I2 = 95%; very low‐quality evidence). No adverse events were reported in the control group. BoNT‐A versus placebo or sham BoNT‐A improves overall gait scores at short‐term (RR 1.66, 95% CI 1.16 to 2.37, P = 0.006; 4 studies, 261 assessments) and medium‐term (RR 1.90, 95% CI 1.32 to 2.74, P < 0.001; 3 studies, 248 assessments) follow‐up, and may improve peak ankle dorsiflexion in stance (MD 15.90 degrees, 95% CI 4.87 to 26.93, P = 0.005; 1 study, 19 children) and in swing (MD 10.20 degrees, 95% CI 4.01 to 16.39, P = 0.001; 1 study, 19 children) at short‐term follow‐up (all moderate‐quality evidence). BoNT‐A is not more effective than placebo or sham at improving function at short‐term (SMD 0.24, 95% CI −0.35 to 0.83, P = 0.42; 4 studies, 305 children) or long‐term (SMD −0.07, 95% CI −0.48 to 0.35, P = 0.76; 2 studies, 91 children) follow‐up, but has a small positive effect at medium‐term follow‐up (SMD 0.28, 95% CI 0.06 to 0.49, P = 0.01; 5 studies, 327 children) (all moderate‐quality evidence). BoNT‐A improves passive ankle range of motion, satisfaction, and ankle plantarflexors spasticity at one or more time points (moderate‐quality evidence). There was no difference between groups in the rate of adverse events at short‐term follow‐up (RR 1.29, 95% CI 0.87 to 1.93, P = 0.21; 12 studies, 918 children; moderate‐quality evidence). BoNT‐A versus serial casting There was no difference between groups for overall gait scores at short‐term (MD 0.00, 95% CI −1.66 to 1.66); medium‐term (MD 0.65, 95% CI −1.21 to 2.51); or long‐term (MD 0.46, 95% CI −1.33 to 2.25) follow‐up in one study with 18 children (moderate‐quality evidence). BoNT‐A improved instrumented gait analysis only in terms of ankle dorsiflexion at initial contact (MD 6.59 degrees, 95% CI 1.39 to 11.78, P = 0.01; 2 studies, 47 children). There was no difference between groups for peak ankle dorsiflexion in stance and swing, and gait speed at any time point (moderate‐ and low‐quality evidence). BoNT‐A is not more effective than serial casting at improving function, ankle range of motion, and spasticity at any time point (moderate‐ and low‐quality evidence). BoNT‐A is not associated with a higher risk of adverse events than serial casting (RR 0.59, 95% CI 0.03 to 11.03; 3 studies, 64 children; low‐quality evidence). BoNT‐A versus orthoses There was no difference between groups for function at medium‐term follow‐up (MD 11.14, 95% CI −0.05 to 22.33; 1 study, 43 children), but BoNT‐A is more effective than orthoses at improving hip range of motion and hip adductors spasticity (all very low‐quality evidence). Authors' conclusions The quality of the evidence was low or very low for most of the outcomes analysed. We found limited evidence that BoNT‐A is more effective than placebo or a non‐placebo control at improving gait, joint range of motion, satisfaction, and lower limb spasticity in children with CP, whereas the results for function were contradictory. The rate of adverse events with BoNT‐A is similar to placebo. BoNT‐A is not more effective than ankle serial casting to treat ankle contractures for any of the assessed outcomes, but is more effective than orthotics at improving range of motion and spasticity.


  • The increase of anterior pelvic tilt after crouch gait treatment in patients with cerebral palsy

    by Mauro César de Morais Filho, Francesco Camara Blumetti, Cátia Miyuki Kawamura, Jaqueline Bartelega Rodrigues Leite, José Augusto Fernandes Lopes, Marcelo Hideki Fujino, Daniella Lins Neves


  • Open Access

    Botulinum toxin A in the treatment of the spastic hip in cerebral palsy

    by Francesco C Blumetti, José A Pinto, Brenda Ng Andriolo, Eiffel T Dobashi, Akira Ishida, João Carlos Belloti

  • The ‘trampoline ankle’

    by Francesco C. Blumetti, Luke Gauthier, Paul J. Moroz

    The purpose of this study was to describe a series of patients presenting with medial malleolus Salter–Harris types III and IV fractures (MacFarland fractures) related to trampoline use. In total, 11 patients were reviewed retrospectively (mean age: 11.8 years; four boys and seven girls). Salter–Harris type III fractures were more commonly seen (n=7). Undisplaced fractures were more prevalent (n=6). Six children underwent surgical treatment. Average follow-up time was 17.8 months. A medial physeal bar with subsequent growth arrest and ankle deformity was observed in two patients. More than one user was present on the trampoline at the time of the injury in nine of the reported cases. Medial malleolus growth-plate injuries can be seen after trampoline injuries where multiple users were involved. Potential complications including growth arrest can occur. Level of evidence: Level IV – case series.


  • Does the GMFCS level influence the improvement in knee range of motion after rectus femoris transfer in cerebral palsy?

    by Francesco C. Blumetti, Mauro C. Morais Filho, Cátia M. Kawamura, Michelle O. Cardoso, Daniella L. Neves, Marcelo H. Fujino, José Augusto F. Lopes

    The aim of this study was to evaluate the influence of the Gross Motor Function Classification System (GMFCS) on the outcomes of rectus femoris transfer (RFT) for patients with cerebral palsy and stiff knee gait. We performed a retrospective review of patients seen at our gait laboratory from 1996 to 2013. Inclusion criteria were (i) spastic diplegic cerebral palsy, (ii) GMFCS levels I-III, (iii) reduced peak knee flexion in swing (PKFSw<55°), and (iv) patients who underwent orthopedic surgery with preoperative and postoperative gait analysis. Patients were divided into two groups according to whether they received a concurrent RFT or not at the time of surgery: non-RFT group (185 knees) and RFT group (123 knees). The primary outcome was the overall knee range of motion (KROM) derived from gait kinematics. The secondary outcomes were the PKFSw and the time of peak knee flexion in swing (tPKFSw). We observed a statistically significant improvement in KROM only for patients in the RFT group (P<0.001). However, PKFSw and tPKFSw improved in both groups after surgery (P<0.001 for all analyses). In the RFT group, the improvement in KROM was observed only for patients classified as GMFCS levels I and II. In the non-RFT group, no improvement in KROM was observed in any GMFCS level. In this study, patients at GMFCS levels I and II were more likely to benefit from the RFT procedure.